Skip to main content

Table 2 Antimicrobial susceptibility pattern of CNS isolates

From: Phenotypic and genotypic characterization of biofilm producing clinical coagulase negative staphylococci from Nepal and their antibiotic susceptibility pattern

Antibiotics

Total (n = 214)

S. epidermidis (n = 123)

S. saprophyticus (n = 40)

S. hemolyticus (n = 24)

S. hominis (n = 15)

S. capitis (n = 12)

R

S

R

S

R

S

R

S

R

S

R

S

CNS

 Penicillin

196 (91.6%)

18 (8.4%)

111 (90.2%)

12 (9.8%)

39 (97.5%)

1 (2.5%)

23 (95.8%)

1 (4.2%)

12 (80%)

3 (20%)

11 (91.7%)

1 (8.3%)

 Ciprofloxacin

76 (35.5%)

138 (64.5%)

39 (31.7%)

84 (68.35)

7 (17.5%)

33 (82.5%)

17 (70.8%)

7 (29.2%)

5 (33.3%)

10 (66.75)

8 (66.7%)

4 (33.3%)

 Tetracycline

27 (12.6%)

187 (87.4%)

11 (8.9%)

112 (91.1%)

8 (20%)

32 (80%)

7 (29.2%)

17 (70.8%)

1 (6.7%)

14 (93.3%)

-

12 (100%)

 Clindamycin

63 (29.4%)

151 (70.6%)

30 (24.4%)

93 (75.6%)

13 (32.5%)

27 (67.5%)

9 (37.5%)

15 (62.5%)

5 (33.3%)

10 (66.7%)

6 (50%)

6 (50%)

 Chloramphenicol

19 (8.9%)

195 (91.1%)

9 (7.3%)

114 (92.7%)

5 (12.5%)

35 (87.5%)

1 (4.2%)

23 (95.8%)

2 (13.3%)

13 (86.7%)

2 (16.7%)

10 (83.3%)

 Cefoxitin

143 (6.5%)

71 (33.2%)

73 (59.3%)

50 (40.7%)

29 (72.5%)

11 (27.5%)

21 (87.5%)

3 (12.5%)

10 (66.7%)

5 (33.3%)

10 (83.3%)

2 (16.7%)

 Erythromycin

155 (72.4%)

59 (27.6%)

80 (65%)

43 (35%)

34 (85%)

6 (15%)

21 (87.5%)

3 (12.5%)

10 (66.7%)

5 (33.3%)

10 (83.3%)

2 (16.7%)

 Cotrimoxazole

80 (37.4%)

134 (62.6%)

46 (37.4%)

77 (62.6%)

14 (35%)

26 (65%)

10 (41.7%)

14 (58.3%)

6 (40%)

9 (60%)

4 (33.3%)

8 (66.7%)

 Gentamicin

45 (21%)

169 (79%)

17 (13.8%)

106 (86.2%)

8 (20%)

32 (80%)

14 (58.3%)

10 (41.7%)

15 (100%)

6 (50%)

6 (50%)

  1. R Resistant, S Sensitive